Skip Navigation



JAC Advance Access published online on February 28, 2006

Journal of Antimicrobial Chemotherapy, doi:10.1093/jac/dkl051
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
57/5/891    most recent
dkl051v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Fiori, P. L.
Right arrow Articles by Polonelli, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fiori, P. L.
Right arrow Articles by Polonelli, L.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2006. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org
Received July 28, 2005
Revised December 12, 2005
Accepted February 5, 2006

Original article

In vitro acanthamoebicidal activity of a killer monoclonal antibody and a synthetic peptide

Pier Luigi Fiori 1 *, Antonella Mattana 2, Daniele Dessì 1, Stefania Conti 3, Walter Magliani 3, and Luciano Polonelli 3

1 Department of Biomedical Sciences, Division of Experimental and Clinical Microbiology, University of Sassari, Viale S. Pietro 43/B, 07100 Sassari, Italy
2 Department of Pharmaceutical Sciences, University of Sassari, Sassari, Italy
3 Dipartimento di Patologia e Medicina di Laboratorio, Sezione di Microbiologia, University of Parma, Parma, Italy

* To whom correspondence should be addressed.
Pier Luigi Fiori, E-mail: fioripl{at}uniss.it


   Abstract

Objectives: To evaluate the in vitro microbicidal activity against Acanthamoeba castellanii of a murine monoclonal anti-idiotypic antibody (KTmAb) and a synthetic killer mimotope (KP), which mimic a yeast killer toxin (KT) characterized by a wide spectrum of antimicrobial activity through interaction with specific cell wall receptors, mainly constituted by {beta}-glucans.

Methods: Amoebicidal activity was investigated after incubation of trophozoites under different experimental conditions with laminarinase, KTmAb, KP and a scrambled decapeptide (SP). To confirm the specific interaction of KP with {beta}-glucans, the experiments were also carried out in the presence of laminarin ({beta}1-3-glucan) or pustulan ({beta}1-6-glucan); both glucan molecules were co-incubated with KP or SP.

Results: KTmAb and KP exhibited a time-dependent killing activity, in comparison with SP or heat-inactivated KTmAb; this activity was completely abolished by pre-incubation with laminarin, but not by pustulan. Notably, in vitro amoebicidal activity was observed in the presence of laminarinase, an enzyme that specifically hydrolyses {beta}-glucans. Furthermore, KP specifically inhibited the growth of Acanthamoeba on infected contact lenses and the remaining adherent KP-treated trophozoites appeared strongly damaged.

Conclusions: The results indicate that the expression of {beta}1-3-glucan receptors in the cell membrane is probably modulated during cell growth of A. castellanii and is critical for the killing activity of KT-like molecules. Our data confirm the broad antimicrobial spectra of KTmAb and KP, emphasize the crucial role of {beta}1-3-glucan in microbial physiology and suggest the potential use of KTmAb and KP in the prevention and therapy of Acanthamoeba infections or in preventing Acanthamoeba contamination during storage of contact lenses.

Keywords: Acanthamoeba; antimicrobial peptides; anti-idiotypic antibodies; antibody-derived peptides; killer toxins.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Antimicrob. Agents Chemother.Home page
G. Conti, W. Magliani, S. Conti, L. Nencioni, R. Sgarbanti, A. T. Palamara, and L. Polonelli
Therapeutic Activity of an Anti-Idiotypic Antibody-Derived Killer Peptide against Influenza A Virus Experimental Infection
Antimicrob. Agents Chemother., December 1, 2008; 52(12): 4331 - 4337.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.